HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[A recurrent case of lipid-secreting carcinoma of the breast successfully treated with capecitabine].

Abstract
We herein report a recurrent case of lipid-secreting carcinoma of the breast which was successfully treated with capecitabine. A 50-year-old female underwent a pectoralis-preserving mastectomy for left breast cancer in December 2002. The clinical staging of the disease was T2N1M0 (stage II B) and ER (-), PgR(-), HER2 (1+). Microscopic examinations revealed solid alveolar proliferation in the majority of the tumor cells, which had an abundant foamy cytoplasm. A variable amount of neutral lipid was also identified in the cytoplasm of the tumor cells by Sudan III staining. After the operation, the patient received two courses of systemic chemotherapy using docetaxel (60 mg/m(2)). In March 2004, she was diagnosed to have a recurrence in the thoracic wall. She received radiotherapy (total 50 Gy radiation), but it proved to be ineffective. In June 2004, treatment using capecitabine (2,400 mg/day) was therefore attempted. Two courses of the treatment resulted in a complete response of the tumor. The above patient has since continued to show a complete response with capecitabine for over 3.5 years.
AuthorsRyuichiro Suto, Syungo Miyamoto, Yoshikazu Kaneda, Nobuya Zenpo, Satoru Kurata, Kiyoshi Nakayasu, Toshiaki Kamei
JournalGan to kagaku ryoho. Cancer & chemotherapy (Gan To Kagaku Ryoho) Vol. 35 Issue 9 Pg. 1599-602 (Sep 2008) ISSN: 0385-0684 [Print] Japan
PMID18799920 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Deoxycytidine
  • Capecitabine
  • Fluorouracil
Topics
  • Biopsy
  • Breast Neoplasms (drug therapy, metabolism, pathology, surgery)
  • Capecitabine
  • Deoxycytidine (analogs & derivatives, therapeutic use)
  • Female
  • Fluorouracil (analogs & derivatives, therapeutic use)
  • Humans
  • Lipid Metabolism
  • Mammography
  • Middle Aged
  • Neoplasm Recurrence, Local (drug therapy, metabolism, pathology, surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: